Achieve Life Sciences, Inc. (ACHV)

Achieve Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	15.55	24.77	43.02	35.85	16.71
Cash & Cash Equivalents	15.55	24.77	43.02	35.85	16.71
Cash Growth	-37.24%	-42.42%	20.00%	114.51%	14.06%
Receivables	0.11	0.11	0.15	0	0
Other Current Assets	1.33	2.45	1.42	1.12	0.62
Total Current Assets	16.98	27.33	44.59	36.98	17.33
Property, Plant & Equipment	0.07	0.12	0.06	0.15	0.39
Long-Term Investments	0	0.07	0.18	0	0
Goodwill and Intangibles	2.23	2.45	2.68	2.9	3.12
Other Long-Term Assets	0.09	0	0	0.28	0.24
Total Long-Term Assets	2.39	2.64	2.92	3.32	3.74
Total Assets	19.37	29.97	47.52	40.3	21.08
Accounts Payable	0.62	1.66	0.84	0.33	0.86
Current Debt	16.73	16.13	0.07	0.09	0.2
Other Current Liabilities	3.47	3.81	3.64	2.51	1.81
Total Current Liabilities	20.81	21.6	4.55	2.94	2.87
Long-Term Debt	0.01	0.07	14.92	0.08	0.16
Total Long-Term Liabilities	0.01	0.07	14.92	0.08	0.16
Total Liabilities	20.82	21.67	19.47	3.01	3.03
Total Debt	16.73	16.2	14.99	0.17	0.36
Debt Growth	3.29%	8.04%	8771.60%	-53.31%	1473.91%
Retained Earnings	-165.75	-135.94	-93.59	-60.43	-45.7
Comprehensive Income	0	0	0	0	0
Shareholders' Equity	-1.45	8.3	28.04	37.29	18.05
Net Cash / Debt	-1.19	8.57	28.03	35.68	16.35
Net Cash / Debt Growth	-	-69.41%	-21.45%	118.22%	11.76%
Net Cash Per Share	-0.06	0.81	3.45	13.12	39.66
Working Capital	-3.83	5.73	40.04	34.04	14.47
Book Value Per Share	-0.07	0.78	3.45	13.71	43.78

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).